Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study(vol 22, 498, 2022)

被引：0
|
作者：
Rayer, Cassandra [1 ]
Nachury, Maria [2 ]
Bourreille, Arnaud [3 ]
Roblin, Xavier [4 ]
Peyrin-Biroulet, Laurent [5 ]
Viennot, Stephanie [6 ]
Flamant, Mathurin [7 ]
Laharie, David [8 ]
Caron, Benedicte [5 ]
Dewitte, Marie [1 ]
Siproudhis, Laurent [9 ]
Fumery, Mathurin [10 ]
Bouguen, Guillaume [9 ,11 ]
机构：
[1] Univ Rennes, CHU Rennes, F-35000 Rennes, France
[2] Univ Lille, CHU Lille, Lille, France
[3] CHU Nantes, Nantes, France
[4] CHU St Etienne, St Etienne, France
[5] Nancy Univ Hosp, Dept Gastroenterol, Inserm U954 Deparment Hepatogastroenterol, Vandoeuvre Les Nancy, France
[6] CHU Caen, Caen, France
[7] Clin Jules Vernes, Nantes, France
[8] Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol & Oncol Digest, CHU Bordeaux, F-33000 Bordeaux, France
[9] Univ Rennes, Inst NUMECAN Nutrit Metab & Canc, CHU Rennes, INSERM,CIC 1414, F-35000 Rennes, France
[10] Univ Picardie, Serv Hepatogastroenterol & Oncol Digest, CHU Amiens & PeriTox, UMR I0 I, Amiens, France
[11] Serv Malad Appareil Digest, 2 Rue Henri Le Guillou, F-35033 Rennes, France
来源：
BMC GASTROENTEROLOGY | 2023年 / 23卷 / 01期
关键词：
D O I：
10.1186/s12876-022-02636-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study
    Hupe, Marianne
    Riviere, Pauline
    Nancey, Stephane
    Roblin, Xavier
    Altwegg, Romain
    Filippi, Jerome
    Fumery, Mathurin
    Bouguen, Guillaume
    Peyrin-Biroulet, Laurent
    Bourreille, Arnaud
    Caillo, Ludovic
    Simon, Mireille
    Goutorbe, Felix
    Laharie, David
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 852 - 860
  • [12] Efficacy of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF
    Mozziconacci, Nicolas
    Vermeire, Severine
    Laharie, David
    Louis, Edouard
    Bigard, Marc-Andre
    Hebuterne, Xavier
    Bouhnik, Yotam
    Van Assche, Gert A.
    Lemann, Marc
    Rutgeerts, Paul J.
    Colombel, Jean-Frederic
    Allez, Matthieu
    GASTROENTEROLOGY, 2008, 134 (04) : A663 - A663
  • [13] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [14] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
  • [15] Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients
    Eroglu, Z.
    Yilmaz, V.
    Er, R. E.
    Soykan, I.
    Toruner, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1182 - I1182
  • [16] Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
    Gisbert, Javier P.
    Chaparro, Maria
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [17] Infliximab as Second Anti-TNF Agent in Crohn's Disease: Durability and Tolerance of Therapy
    Gonzaga, Jason E.
    Zadvornova, Yelena
    Stein, Daniel J.
    Perera, Lilani P.
    Naik, Amar S.
    Venu, Nanda
    GASTROENTEROLOGY, 2012, 142 (05) : S249 - S249
  • [18] Efficacy of ustekinumab in patient with Crohn's disease and anti-TNF induced psoriasis
    Moreno-Suarez, Fatima
    del Carmen Salazar-Nievas, Maria
    Aceituno-Madera, Pedro
    Bautista-Martinez, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB121 - AB121
  • [19] Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Adimadhyam, Sruthi
    Hou, Laura
    Simon, Andrew L.
    Dobes, Angela
    Parlett, Lauren E.
    Haynes, Kevin
    Selvan, Mano
    Ma, Qianli
    Nair, Vinit
    Burris, Jessica L.
    Dorand, Jennifer E.
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S519 - S520
  • [20] Responses to ustekinumab in the anti-TNF agent-naive vs. anti-TNF agent-exposed patients with psoriasis vulgaris
    Clemmensen, A.
    Spon, M.
    Skov, L.
    Zachariae, C.
    Gniadecki, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) : 1037 - 1040
12345